HomeCARM • NASDAQ
Carisma Therapeutics Inc
add
$0.28
9.93%
After Hours:(1.06%)+0.0030
$0.29
Closed: Sep 18, 5:45:32 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.35M | -39.68% |
Net income | -9.77M | 12.44% |
Net profit margin | — | — |
Earnings per share | -0.13 | 52.07% |
EBITDA | -5.78M | 49.38% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.00M | -95.23% |
Total assets | 5.01M | -91.55% |
Total liabilities | 51.02M | -13.50% |
Total equity | -46.01M | — |
Shares outstanding | 41.79M | — |
Price to book | -0.29 | — |
Return on assets | -137.80% | — |
Return on capital | 36.74% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -9.77M | 12.44% |
Cash from operations | -5.90M | 63.37% |
Cash from investing | 163.00K | 253.77% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -5.74M | 64.46% |
Free cash flow | -1.02M | 88.11% |
Previous close
$0.31
Day range
$0.28 - $0.33
Year range
$0.14 - $1.27
Market cap
11.61M USD
Avg Volume
17.30M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2008
Headquarters
Website
Employees
46
